376 related articles for article (PubMed ID: 20686112)
21. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
22. Beta-arrestin-biased ligands at seven-transmembrane receptors.
Violin JD; Lefkowitz RJ
Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
[TBL] [Abstract][Full Text] [Related]
23. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
[TBL] [Abstract][Full Text] [Related]
24. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
[TBL] [Abstract][Full Text] [Related]
25. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2005 Apr; 280(15):15315-24. PubMed ID: 15699045
[TBL] [Abstract][Full Text] [Related]
26. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
27. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.
Luttrell LM; Roudabush FL; Choy EW; Miller WE; Field ME; Pierce KL; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2449-54. PubMed ID: 11226259
[TBL] [Abstract][Full Text] [Related]
28. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
[TBL] [Abstract][Full Text] [Related]
29. Beta-arrestin-mediated localization of smoothened to the primary cilium.
Kovacs JJ; Whalen EJ; Liu R; Xiao K; Kim J; Chen M; Wang J; Chen W; Lefkowitz RJ
Science; 2008 Jun; 320(5884):1777-81. PubMed ID: 18497258
[TBL] [Abstract][Full Text] [Related]
30. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
Willoughby EA; Collins MK
J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
[TBL] [Abstract][Full Text] [Related]
31. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
32. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
33. Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4.
Shukla AK; Kim J; Ahn S; Xiao K; Shenoy SK; Liedtke W; Lefkowitz RJ
J Biol Chem; 2010 Sep; 285(39):30115-25. PubMed ID: 20650893
[TBL] [Abstract][Full Text] [Related]
34. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
35. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
Rajagopal S; Kim J; Ahn S; Craig S; Lam CM; Gerard NP; Gerard C; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):628-32. PubMed ID: 20018651
[TBL] [Abstract][Full Text] [Related]
36. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
[TBL] [Abstract][Full Text] [Related]
37. Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin. Influence of the AT1 receptor conformation on scissile site selection.
Lee C; Bhatt S; Shukla A; Desnoyer RW; Yadav SP; Kim M; Jang SH; Karnik SS
J Biol Chem; 2008 Aug; 283(31):21612-20. PubMed ID: 18505723
[TBL] [Abstract][Full Text] [Related]
38. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.
Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the rat angiotensin type 1a receptor by an upstream short open reading frame.
Kadam PS; Mueller SC; Ji H; Liu J; Pai AV; Ma J; Speth RC; Sandberg K
Peptides; 2021 Jun; 140():170529. PubMed ID: 33744369
[TBL] [Abstract][Full Text] [Related]
40. Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR.
Yang F; Yu X; Liu C; Qu CX; Gong Z; Liu HD; Li FH; Wang HM; He DF; Yi F; Song C; Tian CL; Xiao KH; Wang JY; Sun JP
Nat Commun; 2015 Sep; 6():8202. PubMed ID: 26347956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
